SCHEMBL10574471

SCHEMBL10574471

O=C(Cc1ccccn1)Nc1nc(-c2ccccc2)cs1

nearest known ligand 0.71

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.71
▸ ELOVL1 Q9BW60 2/20 0.70
▸ SLC12A2 P55011 1/20 0.69
▸ SLC12A5 Q9H2X9 1/20 0.69
▸ ROCK1 Q13464 2/20 0.66
▸ PRKACA P17612 1/20 0.66
▸ MAPT P10636 2/20 0.65
▸ MEN1 O00255 1/20 0.65
▸ KMT2A Q03164 1/20 0.65
▸ LMNA P02545 1/20 0.65
▸ MAPK1 P28482 1/20 0.65
▸ SMN1; SMN2 Q16637 1/20 0.65
▸ ROCK2 O75116 1/20 0.64
▸ WNT3A P56704 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26884092 0.91 SLC12A2 (0.64) POLBELOVL1SLC12A2SLC12A5ROCK1
SCHEMBL19380614 0.83 ELOVL1 (1.00) ELOVL1SLC12A2SLC12A5ROCK1PRKACA
SCHEMBL16440383 0.81 NPC1 (0.59) POLBSLC12A2SLC12A5ROCK1MAPT
SCHEMBL15400878 0.80 LMNA (0.73) POLBMAPTMEN1KMT2ALMNA
SCHEMBL225327 0.80 ELOVL1 (0.74) ELOVL1ROCK1PRKACAMAPTMEN1
SCHEMBL13357604 0.80 ROCK1 (1.00) ELOVL1ROCK1PRKACAMAPTMEN1
SCHEMBL13888016 0.79 ROCK1 (0.80) ROCK1MAPK1
SCHEMBL12303085 0.79 WNT3A (0.90) ELOVL1ROCK1PRKACAMAPTMEN1
SCHEMBL8402291 0.79 MAPT (0.73) ELOVL1SLC12A2SLC12A5MAPTMEN1
SCHEMBL1357607 0.79 ELOVL1 (0.72) ELOVL1ROCK1PRKACAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4877795-A 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like KISSEI PHARMACEUTICAL CO., LTD. (JP) 1989-10-31 — — US disclosed
EP-0277755-A1 4H-quinolizin-4-one compounds exhibiting therapeutic activities Kissei Pharmaceutical Co. Ltd. (JP) 1988-08-10 — — EP disclosed
Send feedback